Glaukos says late-stage eye disease treatment shows lasting benefits after single dose
Oct 7 (Reuters) – Glaukos said on Wednesday patients treated with its late-stage eye disease therapy maintained improvements in vision and corneal shape three years after a single treatment for keratoconus, a disease that can progressively distort vision. • The medtech firm said patients who receive




















